
Viatris Inc — Investor Relations & Filings
Viatris Inc. is a global healthcare company focused on empowering people to live healthier at every stage of life. The company operates by bridging the divide between generic and branded medicines, combining aspects of both to enhance patient access worldwide. Its portfolio comprises a wide range of high-quality medicines, including oral solid doses, injectables, complex dosage forms, and active pharmaceutical ingredients (APIs). These products cover numerous therapeutic areas, addressing both noncommunicable and infectious diseases. Viatris's offerings treat many of the World Health Organization's leading causes of death. The company continues to expand its capabilities, including recent acquisitions to strengthen its presence in the central nervous system (CNS) therapeutic area.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2025-12-05 | English | |
| 8-K/A | 2025-12-05 | English | |
| Europaische Studie zeigt sinkende Preise, steigende Kosten und Engpasse - Ergebnisse einer unabhangigen Studie, die wahrend der World AMR Awareness Week von Viatris und Medicines for Europe vorgestell | 2025-11-20 | German | |
| European study shows falling prices, rising costs and shortages - findings from independent study presented during World AMR Awareness Week by Viatris and Medicines for Europe | 2025-11-19 | English | |
| Major Shareholding Notification 2025 | 2025-11-10 | English | |
| 10-Q | 2025-11-06 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 13212625 | 8-K | 2025-12-05 | English | ||
| 13212626 | 8-K/A | 2025-12-05 | English | ||
| 8473424 | Europaische Studie zeigt sinkende Preise, steigende Kosten und Engpasse - Ergebnisse einer unabhangigen Studie, die wahrend der World AMR Awareness Week von Viatris und Medicines for Europe vorgestell | 2025-11-20 | German | ||
| 8466976 | European study shows falling prices, rising costs and shortages - findings from independent study presented during World AMR Awareness Week by Viatris and Medicines for Europe | 2025-11-19 | English | ||
| 13212627 | Major Shareholding Notification 2025 | 2025-11-10 | English | ||
| 13212630 | 10-Q | 2025-11-06 | English | ||
| 13212629 | 8-K | 2025-11-06 | English | ||
| 13212632 | 8-K | 2025-10-24 | English | ||
| 13212631 | ARS | 2025-10-24 | English | ||
| 13212633 | DEFA14A | 2025-10-24 | English | ||
| 13212634 | DEF 14A | 2025-10-24 | English | ||
| 13212635 | Major Shareholding Notification 2025 | 2025-10-17 | English | ||
| 13212636 | FORM 4 | 2025-09-12 | English | ||
| 13212638 | Regulatory Filings 2025 | 2025-09-11 | English | ||
| 13212639 | FORM 4 | 2025-08-19 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Viatris Inc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30502/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30502 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30502 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30502 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30502}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Viatris Inc (id: 30502)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.